Login / Signup

Use of Teriparatide in preventing delayed bone healing and nonunion: a multicentric study on a series of 20 patients.

Gabriele GariffoVanna BottaiFederico FalcinelliFederico Di SaccoRoberta CifaliElisa TroianoRodolfo CapannaNicola MondanelliStefano Giannotti
Published in: BMC musculoskeletal disorders (2023)
In accordance to Literature, this study suggests that Teriparatide plays a potentially important role in the treatment of some forms of delayed unions or nou-nions, even in the presence of failure of hardware. The results suggest a greater effect of the drug when associated with a condition in which the bone is in an active phase of callogenesis, or with a "revitalizing" treatment which represents a local (mechanical and/or biological) stimulus to the healing process. Despite the small sample size and the variety of cases, the efficacy of Teriparatide in treating delayed unions or nonunions emerged, highlighting how this anabolic therapy can represent a useful pharmacological support in the treatment of such a pathology. Although the results obtained are encouraging, further studies, particularly prospective and randomized, are needed to confirm the efficacy of the drug, and define a specific treatment algorithm.
Keyphrases
  • bone mineral density
  • randomized controlled trial
  • combination therapy
  • newly diagnosed
  • deep learning
  • drug induced
  • chronic kidney disease
  • smoking cessation
  • soft tissue